Covalently closed-circular hepatitis B virus DNA reduction with entecavir or lamivudine

AIM: To investigate the reduction in hepatitis B virus (HBV) covalently closed-circular DNA (cccDNA) with entecavir (ETV) or lamivudine (LAM). METHODS: This analysis included patients who had participated in the randomized Phase III study ETV-022 comparing ETV vs LAM in nucleos(t)ide-naive, HBeAg-po...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:World J Gastroenterol
Auteurs principaux: Bowden, Scott, Locarnini, Stephen, Chang, Ting-Tsung, Chao, You-Chen, Han, Kwang-Hyub, Gish, Robert G, de Man, Robert A, Yu, Miao, Llamoso, Cyril, Tang, Hong
Format: Artigo
Langue:Inglês
Publié: Baishideng Publishing Group Inc 2015
Sujets:
Clinical Trials Study
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4402312/
https://ncbi.nlm.nih.gov/pubmed/25914474
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v21.i15.4644
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires